Arjan Diepstra

Associate professor in Hematopathology Profile

Associate professor in Hematopathology

I am a consulting hematopathologist, research programme leader of the SALL and a scientist. My research is focused on basic and translational aspects of lymphoma, especially Hodgkin lymphoma, a fascinating disease that offers great opportunities to study cancer immunology. I have a special interest in the tumor microenvironment, antigen presentation and immune checkpoints and aim to translate my research findings to clinical benefits for patients. To accomplish that I am a working group leader in the EORTC lymphoma group and the Interlymph consortium and a member of HOVON.

Discover our research

publication

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies

2024, European Journal of Cancer

publication

Muscle Mass, Muscle Strength, and Health-Related Quality of Life in Kidney Transplant Recipients: Results of the TransplantLines Biobank and Cohort Study

2024, Kidney International Reports

All publications

- Changes in the classification of lymphoid neoplasms in the new WHO classificationArjan Diepstra (Invited speaker) 13-Dec-2022 Academic presentation > Academic
- Serum TARC levels indicate Hodgkin lymphoma years before diagnosisArjan Diepstra (Speaker) 24-Oct-2022 Academic presentation > Academic
- Signaling pathways and immune evasion in Hodgkin lymphomaArjan Diepstra (Speaker) 7-Sep-2022 Academic presentation > Academic
- Annual Interlymph MeetingArjan Diepstra (Organiser) 14-Jun-2022 Organising and contributing to an event > Academic
- HLA expression in relation to susceptibility alleles in follicular and diffuse large B cell lymphomaArjan Diepstra (Speaker) 14-Jun-2022 Academic presentation > Academic
All activities
- Appointment Coordinating Committee Member International Interlymph ConsortiumArjan Diepstra, Nov-2022 Academic
- Expert in LymphomaArjan Diepstra, Dec-2021 Academic
- Translational research Transplant-BRAVE trialArjan Diepstra, 2020 Academic
- Karl Musshoff PrizeArjan Diepstra, Oct-2016 Academic
All prizes

Arjan Diepstra

Discover our research

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies

Muscle Mass, Muscle Strength, and Health-Related Quality of Life in Kidney Transplant Recipients: Results of the TransplantLines Biobank and Cohort Study

Contact

Footer navigatie

UMCG Research

Researchers

About UMCG

Arjan Diepstra

Discover our research

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies

Muscle Mass, Muscle Strength, and Health-Related Quality of Life in Kidney Transplant Recipients: Results of the TransplantLines Biobank and Cohort Study

Activities

Prizes

Contact

UMCG Research

Researchers

About UMCG